STAT3 and renal cell carcinoma: In accordance with these findings, STAT3 inhibitor WP1066 has been shown to induce apoptosis, and inhibit the basal and hypoxia-induced expression of HIF1α and HIF2α, as well as VEGF secretion in RCC cell lines [89].